Navlimetostat

DRUG2 trials

Sponsors

Bristol-Myers Squibb, M.D. Anderson Cancer Center

Conditions

Healthy ParticipantsNon-Small Cell Lung Cancer

Phase 1

A Phase 1 Study of Navlimetostat Tablet Formulations

RecruitingNCT07544628

Bristol-Myers SquibbHealthy Participants

Start: 2026-04-27End: 2026-10-15Target: 64Updated: 2026-05-14

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

Not yet recruitingNCT07579221

M.D. Anderson Cancer CenterNon-Small Cell Lung Cancer

Start: 2026-11-30End: 2031-08-01Target: 17Updated: 2026-05-12